196205-06-8 Usage
Uses
Used in Organic Synthesis:
4-Methyl-5-aminoindole is used as a building block in organic synthesis for the creation of various pharmaceuticals and agrochemicals. Its distinctive molecular structure and reactivity contribute to the development of a broad spectrum of chemical compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 4-Methyl-5-aminoindole serves as a key intermediate, facilitating the synthesis of pharmaceuticals with potential therapeutic applications.
Used in Dye and Pigment Production:
4-Methyl-5-aminoindole is utilized as a starting material in the production of dyes and pigments, capitalizing on its chemical properties to yield a range of colorants for various industries.
Used in Anticancer Research:
4-Methyl-5-aminoindole has been studied for its potential biological activities, particularly as a starting material for the synthesis of compounds with anticancer properties, indicating its role in the development of novel therapeutic agents.
Used in Catalyst Development:
Additionally, 4-Methyl-5-aminoindole is employed as a ligand in the development of new catalysts, highlighting its importance in advancing chemical processes and reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 196205-06-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,6,2,0 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 196205-06:
(8*1)+(7*9)+(6*6)+(5*2)+(4*0)+(3*5)+(2*0)+(1*6)=138
138 % 10 = 8
So 196205-06-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H10N2/c1-6-7-4-5-11-9(7)3-2-8(6)10/h2-5,11H,10H2,1H3
196205-06-8Relevant academic research and scientific papers
5- AND 6-(2-IMIDAZOLIN-2-YLAMINO) AND -(2-THIAZOLIN-2-YLAMINO)-BENZOTHIAZOLES AS ALPHA-2 ADRENERGIC LIGANDS
-
, (2008/06/13)
This invention is directed to indole and benzothiazole compounds which are selective for cloned human alpha 2 receptors. This invention is also related to uses of these compounds for any indication where use of an alpha 2 agonist may be appropriate. Specifically, this includes use as analgesic, sedative and anaesthetic agents. In addition, this invention includes using such compounds for lowering intraocular pressure, presbyopia, treating migraine, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, ischemic pain, spasticity, diarrhea, nasal decongestion, urinary incontinence as well as for use as cognition enhancers and ocular vasoconstriction agents. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.
